In May 2017 HypoPet AG announced a merger with Saiba Animal Health GmbH. Saiba Animal Health’s CAD vaccine (partnered with Benchmark Holdings PLC) and product pipeline of novel vaccine candidates subsequently became part of HyopPet’s product candidate pipeline .Read More
Archive: May 1, 2017
- Saiba Animal Health AG enters into an Agreement with Boehringer Ingelheim
- HypoPet led consortium receives top ranking and funding from Eurostars Program for the research and development of a vaccine for African Swine Fever.
- HypoPet Enters Into an Agreement with a Major Animal Health Company
- Key preclinical data for HypoPet’s cat allergy vaccine (HypoCat™ / VC001) published in leading allergy journal.
- HypoPet AG today announced the publication of proof of principle data for a vaccine with the potential to translate into a novel therapy for osteoarthritic pain in companion animals